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This evidence into practice briefing aims to help reduce
the morbidity and mortality associated with drugs use by
providing evidence-based information on interventions
that prevent or help delay its onset, reduce the harms
associated with it and promote cessation.
This briefing is for professional groups in the statutory,
voluntary and private sectors. These are listed below,
along with a summary of key information relevant to
each group. Figures in brackets refer to relevant sections
of the briefing.
1.1  Executives, senior managers, commissioners and
budget holders: 
• Public health professionals (for example, directors of
public health (DPHs) and community development staff) 
• Policy and decision makers (for example, those working
in regional government offices, strategic health
authorities (SHAs), the Drug Strategy Directorate (DSD)
and cross-governmental drugs misuse specialists 
• Commissioners and budget holders (for example,
members of primary care trusts (PCTs), drug and
alcohol action teams (DAATs) chairs and managers,
and joint commissioners working in local authorities
and the NHS
• Children’s trusts.
1.1.1  Key evidence for this group of stakeholders
supports:
• Development of evidence-based public health policy to
promote the prevention of drug use among young
people, particularly those in deprived communities 
(4, 5.6)
• Promotion, support and development of leadership
skills to tackle health inequalities with regards to drug
use (5.6)
• Needs and health impact assessments to determine
which interventions will work best for a particular
population (5.6, 6.4, 8)
• Identification of the community, structural and cultural
barriers to developing integrated drug prevention
programmes and how these barriers can be overcome
(6.2, 6.4)
• Work with local strategic partnerships to implement pilot,
community-based ‘holistic’ prevention programmes
involving a number of components (5.5, 6.3)
• Allocation of resources to pilot new or innovative,
evidence-based interventions via local strategic
partnerships (6.3)
• Organisation and workforce development to support
delivery of drug prevention interventions. This should
include accredited and/or standardised training, and
independent monitoring of multi-agency working (5.3,
6.2, 6.3)
• Longer-term funding in response to evaluation
evidence showing effectiveness (4)
• Realistic outcomes and definitions of success shared by
all stakeholders and professional groups (6.3)
• The use of ‘alternative’ evaluators, such as funded
PhDs, standardised training workshops and courses for
drug professionals (6.3).
1.2  Service providers:
• Drug treatment services 
• Advocate groups 
• Tier 1 and 2 young people’s substance misuse services 
• Resource developers 
• Counselling services 
• Youth offending teams (YOTs) 
• Youth offender institutions (YOIs) 
• Youth organisations 
• Social workers 
• Leaving care teams.
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1  Summary
1.2.1  Key evidence for this group of stakeholders
supports:
• An awareness of individual and group barriers to
engaging with services and how to help young people
identify, manage and resolve risky (drug-related)
behaviours (6.4, 6.5) 
• A view of young people’s drugs use which looks at the
broader context of their lives (improving their general
health, social skills and education) may be more
important than focusing specifically on health
outcomes (3, 6.3, 6.4)
• Maintenance of non-drugs using behaviour by
promoting and reinforcing protective factors (for
example, positive experiences at school, in the social
environment or with the family)
• Research and evaluation (process, fidelity and
outcome) as a means of improving practice, with
evaluation fully integrated from the intervention’s
conception (6.3)
• Discussion of project successes and failures, so
contributing to Drug Education and Prevention
Information Service (DEPIS) and Exchange on Drug
Demand Reduction Action (EDDRA), two online
databases that provide projects and resources for
planners and providers of drugs prevention (7)
• Work with the media to present positive views of
young people and rational, evidence-based information
about drugs and drug use (5.5)
• The ability to influence and determine local and national
discourse and priorities on drugs and drugs use (5.6)
• Active participation in training and professional
development (5.3, 6.2)
• Work at national and local level to disseminate
intervention and research outcomes through a variety
of media and presentation techniques (6.4, 7)
• Monitoring of sources of referral, and the appropriate
use – and quality of – external providers (including
professional trainers and invited speakers) and
resources (5.3.2, 6.4).
1.3  Community-based professionals:
• Healthcare professionals (for example, general
practitioners, practice nurses, health promoters)
• Education specialists (for example, teachers in
mainstream education and schools for excludees) and
school drugs officers
• Community organisations
• Youth groups.
1.3.1  Key evidence for this group of stakeholders
supports:
• Working with all sectors, in all settings, to ensure
suitable and sensitive referrals, appropriate information
sharing, network development and effective
community engagement (4, 6.4, 6.5)
• Identification of training needs and delivery of training
to individuals and groups (including volunteer groups)
to help them develop and deliver drug prevention
interventions (5.3, 6.2)
• Assessment of needs, resources and capacity to
develop and deliver community-based drugs prevention
programmes (4, 5.1, 5.2, 5.6, 6.5)
• Community profiling to identify structural and cultural
barriers preventing development of community-based
drug programmes and how to overcome those barriers
(6.2)
• Community participation in the development of
community-based drug prevention programmes such as
health promotion, health education, awareness raising
and other community development activities (6.2)
• The recognition of potential community leaders and
champions (6.2)
• Integration of community-based drug prevention
programmes with other initiatives (for example, in
schools via the national curriculum and Healthy Schools
and via initiatives supported by the Neighbourhood
Renewal Fund (NRF)) (5.5).
1.4  Academics, designers, planners and evaluators
of drug prevention projects
• Health professionals and drugs experts based in
universities, government departments, DAATs, PCTs,
LEAs and SHAs.
1.4.1  Key evidence for this group of stakeholders
supports:
• The creation and evaluation of a wide range of
activities based on drug prevention theories (5.4.1, 5.6,
6.3, 8).
• Identification of determinants of drug misuse as well as
protective factors – in particular, associated behaviours
which may be amenable to change (3, 3.1, 6.4).
• Refining and testing interventions for behavioural
change and education, with reference to:
– ‘real world’ implementation
– gender differences
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– sensation seeking and risk-taking behaviours (which 
require definition and description)
– perceptions of harm (including relative and absolute 
drugs risks), and cognitive and affective risk 
awareness
– generic behavioural change
– social norms and sociocultural beliefs
– teaching methods and knowledge transfer 
(pedagogy and epistemology)
– iatrogenic effects of intervention. 
(5.1, 5.2.1, 5.4, 6.3, 6.4, 8).
• Conducting, promoting and then disseminating the
findings of high-quality interventions, describing:
– confounding factors and sources of bias
– population (type of user, control group, entry and 
exclusion criteria, attrition)
– nature of the intervention and facilitators/providers
– specific and clearly defined outcomes (qualitative and
quantitative assessments of behaviours addressed, 
units of analysis at individual, school or community 
level)
– duration of effect
– causation and mechanisms of change
– assessment of fidelity, practicality, transferability and 
cost effectiveness (5.4, 5.5, 6.3, 7).
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This briefing presents evidence-based information on how
to prevent drugs misuse. It integrates published scientific
literature with practitioner expertise and experience,
including advice on how to overcome typical barriers and
obstacles to effective practice.
2.1  How was this briefing developed?
This briefing is based on evidence from Drug use
prevention among young people: a review of reviews
(Canning et al. 2004), rapid reviews of the grey literature
(Coomber et al. 2004a, 2004b; Millward et al. 2004), 
and National Collaborating Centre for Drug Prevention
(NCCDP) reviews of the evidence base (Edmonds et al.
2005; McGrath 2006).
The most ‘plausible’ interventions were appraised 
by practitioners to determine those most likely to
succeed. Typical barriers and opportunities for local
implementation were also identified. The methodology is
described elsewhere (Sumnall et al. 2005) and is
summarised in Figure 1. 
Briefly, key literature was systematically evaluated using a
proforma and a ‘long list’ of 12 recommendations was
constructed. This was discussed with an international
group of experts that rated each recommendation in
terms of appropriateness and likely effectiveness. The
long list was then further refined to a shortlist of key
prevention categories, programme delivery, design and
content, research and indicated (particularly vulnerable)
groups. 
The detail was discussed at a series of fieldwork meetings
involving practitioners, academics and local/regional
commissioners and planners of drug services for young
people. The discussions were transcribed and analysed to
identify common themes, barriers to implementation and
solutions. Consensus was reached through an expert
meeting, and the final evidence is presented in this
briefing.
2.2  Why focus on drugs misuse in young
people? 
2.2.1  What is the problem? 
While there are no current data on the drugs used by
children under 10 years old, in 2004 10% of 11–15 year
olds reported taking drugs in the previous month
(National Centre for Social Research/National Foundation
for Educational Research 2005). UK schoolchildren
(15–16 year olds) consistently report higher levels of
lifetime use of any illegal drug than other European
citizens (36% versus 16%) (Hibell et al. 2004). According
to the British Crime Survey, people aged 16–24 are more
likely than older people to have used drugs in the last
year and in the last month (Condon and Smith 2003).
Although reported use fluctuates, young people’s
perception of the prevalence of drug use among their
peers generally does not change.
2.2.2  Why prevent drugs misuse in young
people?
This age group reports the highest level of drugs use in
the general population and will suffer the most years of 
ill health if adversely affected. Drugs use may have a
negative effect on psychological development, and
accumulating evidence suggests that people who start
using drugs at an early age perform worse at school and
have fewer employment prospects than abstainers
(Hickman et al. 2004; Lynskey and Hall 2000). Twin
studies suggest that they are also more likely to go on to
– or become dependent on – multiple substances
(Lynskey et al. 2003).
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2  Introduction
2.2.3  What is the policy context?
The Updated Drug Strategy 2002 (see www.drugs.gov.uk)
aims to reduce the use of class A drugs – and the
frequent use of all illicit drugs – by all young people 
(< 25 years old) and, in particular, the most vulnerable, by
2008. ‘Choosing not to take illegal drugs’ is a key aim of
Every Child Matters: Change for Children – Young People
and Drugs (DfES 2005). A simplified and strengthened set
of key performance indicators in relation to children and
young people are being developed via the National Drug
Strategy Performance Management Framework for
2005/2006. These reflect the contribution of mainstream
services through universal interventions (including drugs
education, advice and information, prevention, and via
access to core services), targeted interventions with
vulnerable young people, specialist treatment for young
people, and the involvement of parents, carers, and
families.
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Reviews of drug
prevention
Production of 
long list of
Recommendations
1 Key literature approached systematically
2 Main findings appraised according to 
standardised criteria
3 Long list agreed after consultation
Production of 
short list of 
recommendations
1 Twelve recommendations refined by NCCDP
2 NCCDP Network Group consulted 
(questionnaire assessment)
3 Short list of four topics agreed
Academics and
researchers
Local 
government and
commissioners
Local practitioners
and user groups
Regional 
government and
commissioners
Production of 
fieldwork report
(embryonic action
briefing)
Consensus
through meeting
of key experts
Action briefing for the
prevention of drug use
in young people
1 Analysis of data from field meetings
2 Thematic report circulated
3 Final recommendations
Field meetings
Figure 1: Methodology
The health of populations and individuals is influenced by
a number of inter-connected determinants.
• Environment – physical, economic and social conditions
(including education, employment and housing)
• Lifestyle – personal behavioural choices that increase or
decrease the risk of ill health
• Services – provision and use.
Drugs use may be thought of in the context of these
determinants. 
3.1  Why do people take drugs? 
The choice to use a particular drug involves sophisticated
decisions and risk assessments. But drugs are usually
taken to produce certain perceived effects and fulfil
specific functions (Boys et al. 1999, 2001; Hansen et al.
2001; Williams and Parker 2001). The World Health
Organization uses the following broad categories of drug
use: 
• Experimental use that might or might not continue
• Functional use that serves some purpose, such as
recreation, but does not cause problems for the user
• Dysfunctional use that leads to impaired
psychological or social functioning
• Harmful use that causes damage to the user’s
physical or mental health
• Dependent use that could involve tolerance and/or
withdrawal symptoms if use is ceased, and continued
use.  
Evidence indicates that certain childhood problems and
personality traits, such as attention deficit behaviours and
sensation seeking/impulsiveness, are associated with an
increased likelihood that someone will experiment with
controlled drugs and develop a medical disorder
associated with drugs use in later life (Giancola et al.
1996; Lynskey and Hall 2001; Tapert and Brown 2000).
However, these are associated risk factors and do not
imply that young people’s drugs use is a pathological or
‘disease state’.
The reasons for initial experimentation and continued use
of drugs are different. Beliefs about the effects may have
an influence independent of biological, sociocultural, and
psychopharmacological factors (Brown et al. 1980). For
example, youths and adults with strong expectations that
alcohol intoxication will have a positive and arousing
effect start drinking at an earlier age and are more likely
to develop drinking problems later in life (Blume et al.
2003; Goldman and Christiansen 1985). Initial
experiences of cocaine use largely determine whether it
becomes habitual. In addition, there are strong links
between the age when an individual first had the
opportunity to use a drug and actual age of first use
(Davidson et al. 1993). 
Users have to make sophisticated cost-benefit analyses if
they are going to continue taking a drug (Parker et al.
1998). Generally, the perceived positive effects (for
example, enhanced mood, perceptual and aesthetic
components) need to outweigh the negative effects 
(for example, criminality, anxiety, ‘hangover’, problems
with education, work, financial state and relationships)
(Van Etten et al. 1998).
In the general population, there is a random propensity
to use drugs. This means that, all other factors being
equal, those individuals who use more problematic drugs
(such as heroin and crack cocaine) do so regardless of
whether or not – or how much – they have used other
drugs such as alcohol, tobacco or cannabis in the past
(Morral et al. 2002). For example, a quarter of one British
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3  The ‘web of determinants’ 
clinical sample reported that they started to use cocaine
and heroin before they began to use other illicit drugs
(Sanju and Hamdy 2005). In addition, people often
continue to take drugs despite their knowledge or
experience of the negative effects or the potential risks
involved (Cottler 
et al. 2001), simply accepting these as part of the overall
drug experience. 
Several groups of young people are particularly vulnerable
to developing problematic drugs use (Canning et al.
2004). These include: homeless young people,
schoolchildren who have been excluded or who truant,
young offenders, cared for children, young people who
work in the sex industry and children of drug-using
parents. These groups are reported to have high levels of
drugs use compared to the general population. 
The 2003 Crime and Justice Survey (Becker and Roe
2005) revealed that reported use of Class A drugs in the
past 12 months was markedly low among young people
in the general population (4%). Among the identified
groups, truants had the highest levels of drugs use (16%)
while those in care had the lowest levels (5%). There may
be particularly vulnerable subsets within these groups:
members of more than one group reported higher levels
of Class A drugs use than members of any one group
(more than one 39%; one group 18%). It must also be
noted that large proportions of young people who
belong to these groups do not take drugs occasionally or
habitually.
A wide variety of risk factors are thought to predict a
move from experimental and irregular use into drugs
dependence. These include: laws and norms favourable
towards drugs use, extreme economic deprivation,
neighbourhoods with high levels of crime and
unemployment, physiological characteristics, family
history of drugs use, academic failure, early peer rejection
and social influences. The variety of determining factors
suggests that drugs use may be a particular manifestation
of a general underlying behavioural state. In other words,
there are a range of factors that can give rise to drugs
use, including other potentially health compromising
behaviours.
The social characteristics of the majority of young
recreational drugs users are no different from the non-
drugs using population (Aust and Condon 2003; Calafat
et al. 1998). Most individuals stop using drugs when they
reach their mid-20s. Often this coincides with their focus
turning to career and family, or it could simply be
because they no longer desire the effects that drugs
produce (Chen and Kandel 1998).
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This section highlights who is responsible for – or can be
engaged in – drugs prevention work with young people.
The way these professionals are grouped together
depends on the web of determinants previously described
and the nature and organisation of services in relation to
drugs prevention. 
Healthcare professionals can refer patients directly or
indirectly (for example, via community development
workers) to appropriate services.
Education specialists provide curricular-based
interventions and are key contacts for external drugs
education providers. Provision for school excludees includes
tailored interventions to meet their needs. Local drugs
programme coordinators support the drugs prevention
aspects of the National Healthy Schools Programme.
Public health specialists are often responsible for the
allocation of primary care trust (PCT) drugs prevention
funding, and for encouraging local agencies to work
together to achieve the aims of the National Drugs
Strategy. They ensure that all primary healthcare services
provide evidence-based drugs information and that
appropriate links are made with drugs and education
services. They should also be able to make the
epidemiological links between drugs use and other
conditions, so that all services (health or otherwise)
understand their role in drugs prevention.
Drug service providers deliver drug prevention
interventions in a range of settings including schools,
community and youth groups, and through media
campaigns. Additional support is offered according to the
young person’s life circumstances. They recruit young
people to help deliver key messages and to develop their
self-esteem and inter-personal skills, including negotiation
skills.
Local policy makers, budget holders and senior
managers within the NHS and local authorities ensure
resources are allocated to evidence-based, needs driven
drugs prevention activities.
Community organisations can act as recruiters of
young people and service providers. They are often well
placed to monitor uptake and feedback on interventions;
in particular, how they are meeting local needs.
Community development workers can also help promote
local drugs prevention initiatives.
Academics and the designers, planners, and
evaluators of drugs prevention projects identify the
purpose and expected outcomes of a project. All projects
should be theory-driven, practical and based on
appropriate methodology. Successes and failures should
be assessed and shared with a wide audience to help
improve subsequent interventions.
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4  The ‘web of stakeholders’ and the roles 
of different professionals
A review of the literature (Canning et al. 2004; Coomber
et al. 2004a, 2004b; Edmonds et al. 2005) yielded a
number of evidence-based interventions that were likely
to prevent drugs use among young people. The review
also indicated that most interventions were only effective
in the short-term. 
5.1  Programme design and content
The evidence suggests that an effective drug prevention
programme needs to be carefully planned and developed.
Special attention should be given to its structure and
content. The former concerns issues such as length of 
the programme, implementation strategies and the
management, monitoring and evaluation processes.
Content needs to reflect research evidence, the
characteristics of the target population (for example,
gender and age) and its potential cost effectiveness. 
The evidence suggests that:
• school-based drugs prevention programmes have a
small, short-term effect in terms of delaying the onset
of drugs use or reducing the amount of drugs used
(White and Pitts 1998) 
• drugs prevention programmes should take ‘a whole
person approach’, which addresses several different life
issues (including drugs use and drugs-related problems)
(Belcher and Shinitzky 1998; Smyth and Saulnier 1996;
White and Pitts 1998; Windle and Windle 1999)
• the effectiveness of programmes varies according to
gender (White and Pitts 1998). In particular, several
studies found that targeted interventions were more
effective for females than males. Therefore, the
content needs to be gender sensitive
• young people’s attitudes towards drugs can change –
over time and in response to the prevailing societal
climate (Coggans et al. 2003). So programmes need to
be in tune with the social culture and attitudes
towards drugs among the target and general
populations (Coggans et al. 2003; Smyth and Saulnier
1996; White and Pitts 1998).   
5.2  Indicated and targeted groups
Research has shown that particular groups of young
people are more likely to try drugs and/or develop drug-
related problems than the general population. Selective
prevention targets these groups. Indicated prevention
targets individuals who may have already started using
drugs and whose habit is likely to escalate. The HDA
evidence briefing, Drug use prevention among young
people: a review of reviews (Canning et al. 2004)
identified six key groups of ‘at risk’ young people:
• children whose parents use drugs 
• young offenders 
• looked-after children 
• young homeless people 
• schoolchildren who are excluded  
• sex workers. 
These groups are not exclusive: many young people will
be part of more than one group or transfer between
them, and there may be particularly vulnerable subsets of
young people within these groups. Young people from
black and minority ethnic groups (BMEG) are also
considered in the HDA briefing, as the literature suggests
they are particularly vulnerable and face particular barriers
accessing the appropriate services. 
The evidence suggests that:
• universal drugs prevention programmes (those
targeting the whole population, for example, every
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5  The evidence base for effective interventions
student in a school) can be ineffective or even harm
sub-populations who have a higher risk of initiating
drugs misuse and/or developing drugs-related
problems (Windle and Windle 1999). These ‘high risk’
youths may benefit from targeted interventions which
take into account their individual needs (White and
Pitts 1998; Windle and Windle 1999) 
• ‘high risk’ young people need to be identified and
recruited in a sensitive manner, as ‘labelling’ can lead
to stigmatisation and further problems (Smyth and
Saulnier 1996)
• ‘High risk’ youths are more likely to drop out from a
programme (Coggans et al. 2003). Therefore, effective
strategies are needed to retain participants, with a
contingency plan for those who drop out (Allott et al.
1999; Smyth and Saulnier 1996).
5.3  Programme delivery
There are two main issues with programme delivery: who
should be teaching or facilitating the programme and
what teaching methods should be used? 
Drugs prevention programmes have been taught and/or
facilitated by teachers, peers, police officers and other
contributors. A programme can be interactive (offering
contacts and opportunities to exchange ideas and learn
drug refusal skills) or non-interactive, or both. Both the
person delivering the programme and the teaching
methods used need to be appropriate for the age and
culture of the target audience. The evidence suggests
that:
• service providers need standardised and well-
monitored training (Black et al. 1998)
• programmes should be run in an environment that
promotes disclosure, honest feelings and opinions
(Windle and Windle 1999).
5.4  Research 
The effectiveness of a prevention programme or
intervention is greatly improved if it is based on evidence
of effectiveness. The programme or intervention can, in
turn, contribute to the research pool (providing it has
been evaluated) to assess its implementation, operation
and both short- and long-term outcomes. Research
findings should be clearly communicated and effectively
disseminated, so that drugs prevention workers can act
on the evidence in concert with developers, researchers,
and purchasers. The evidence highlights:
• a lack of well-conducted evaluation studies of drugs
prevention programmes with clearly defined outcomes
(Allott et al. 1999; Dusenbury et al. 1997; Smyth and
Saulnier 1996)
• the ‘fidelity of implementation’ (the degree to which
drug prevention providers implement programmes as
intended by the programme developers) can affect
outcomes (Black et al. 1998; Coggans et al. 2003;
White and Pitts 1998; Windle and Windle 1999).
Therefore, programme fidelity needs assessing to ensure
an accurate conclusion is drawn about effectiveness
• many programmes combine different components or
features; however, the effectiveness of each
component was seldom examined separately. This
suggests that programmes should incorporate research
elements to distinguish effective and ineffective
components (Allott et al. 1999; Flay 2000; White and
Pitts 1998).
5.5  Attributes of effective interventions
In addition to the statements above, Canning et al.
(2004) found that programmes which had a positive
impact on drug-related cognitions and/or drugs use had
several common characteristics.
• They tend to use a mix of focused and generic
components/interventions. 
• They tend to include booster sessions or additional
elements that have a similar purpose (White and Pitts
1998). However, other characteristics appeared to have
a stronger influence on the programme’s outcomes
(Coggans et al. 2003; Cuijpers 2002).
• Intensive programmes involving 10 or more sessions
have been shown to be effective. However,
effectiveness cannot be attributed solely to the
intensity of the programme, since some less intensive
programmes demonstrated positive outcomes 
(Black et al. 1998; White and Pitts 1998).
• Interactive programmes were more effective at
preventing drugs use than non-interactive programmes
(Black et al. 1998; Parkin and McKeganey 2000).
• Multi-component programmes (those which address
several life issues by different means and in different
settings) can help prevent drugs use and/or drugs
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problems. These may involve, for example, school,
parents, community organisations and the mass 
media (Botvin 1999a, 1999b; Flay 2000; Lloyd et al.
2000).
• Life skills training programmes demonstrated long-
term, albeit small, prevention effects for tobacco,
alcohol and cannabis use (Dusenbury et al. 1997;
White and Pitts 1998). This was, however, limited to a
sub-population of participants (Coggans et al. 2003;
Gorman 2002) and then only with a high fidelity of
implementation (Coggans et al. 2003).
• Police-led drugs education can have an impact on
attitudes towards the police and drugs knowledge but
its effect on drugs use is limited (Allott et al. 1999).
5.6  Gaps in the evidence base
No review-level evidence was found on the effectiveness
of the following interventions.
• School-based interventions focused on changes in
behaviour among primary schoolchildren (Belcher and
Shinitzky 1998; Lloyd et al. 2000).
• Interventions targeted at particular groups, for
example, vulnerable young people (Dusenbury et al.
1997; Smyth and Saulnier 1996) including those not
attending school (White and Pitts 1998). 
The majority of British studies do not evaluate outcomes
of programmes adequately, but focus more on processes
(Lloyd et al. 2000; White and Pitts 1998). In addition,
methodological problems were prevalent in all drugs
prevention evaluation studies, which limited the strength
of the conclusions in the HDA evidence briefing (Canning
et al. 2004). Methodological issues included:
• low participation rates, inappropriate choice of
outcome measures, absence of appropriate controls
and high rates of attrition (Allott et al. 1999). A lack 
of heterogeneity among evaluation studies was also
highlighted, which makes meaningful comparisons
difficult (Dusenbury et al. 1997)
• many studies relied too heavily on self-reported
measures of drugs use – few used objective data, such
as saliva or blood tests (White and Pitts 1998).
The findings only have a limited relevance to UK drugs
prevention programmes as:
• cultural and societal differences can affect the
effectiveness of programmes and most outcome
evaluation studies were conducted in the USA
• school-based universal prevention programmes do not
reach those young people who have been excluded
from school.
The HDA evidence briefing was limited to a review of
interventions aimed at individuals. Hence, no evidence is
available on the effectiveness of interventions to change
policy, practice or the environmental factors influencing
the onset, experimentation and regular or ‘binge’ use of
drugs.
The absence of evidence on what works for vulnerable
populations must be considered carefully by managers,
policy makers and commissioners of services. Failure to
address the needs of disadvantaged groups when
designing intervention programmes may increase the
gradient of morbidity and mortality across the social
spectrum (because an intervention programme may have
a differential impact on different social groups).
A final caveat is that the absence of evidence does not
necessarily imply lack of effectiveness; interventions made
need to be designed and evaluated more carefully to
demonstrate effectiveness among particular population
groups.
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This section presents the suggestions and observations
that emerged from the fieldwork meetings. They are
linked to the shortlist of evidence drawn from the original
evidence statements (which, in turn, were taken from 
the literature reviews, see section 5). This shortlist
suggests how different stakeholders can overcome
implementation barriers and put evidence into practice. 
The fieldwork meetings were carried out in Liverpool (UK)
during November and December 2004.
6.1  General observations
There is a clear need for consistent definitions of key
terms (see glossary of drugs prevention related terms,
below).
Periods of abstinence are often interspersed with
recreational and problematic drug use during a young
person’s drugs-using ‘career’, although the distinctions
between the latter two may be becoming increasingly
blurred. Drugs ‘careers’ are shaped by the interaction of
individual factors (for example, family background) with
structural opportunities (for example, employment) at
different times. The importance of considering young
people’s lives within the broader context (for example,
socio-economic climate and drugs markets) should be
stressed.
Glossary of drugs prevention related terms 
While this glossary is not comprehensive, it introduces
some of the most important terms used in drugs
prevention work and, hopefully, will be developed further.
Children People under the age of 18 years, in
accordance with the Children Act (1989) and the United
Nations Convention on the Rights of the Child (1989).
Young people People aged under 25 (in line with
Home Office definitions). 
Drugs prevention Interventions that prevent, delay or
reduce the harms associated with drugs use and promote
cessation. There are three main prevention models:
• universal targets the whole population
• selective targets subsets of the population identified
as having a higher than average risk of drug use
• indicated targets those who have already taken drugs
and are considered to be at risk of becoming
dependent.
Drugs/substance These have identical meanings. They
are both agents that, when ingested in sufficient doses
and by appropriate routes, can alter the way a person
functions. In the literature, ‘drugs’ tends to refer to illicit
compounds (as defined in the UK by the Misuse of Drugs
Act, 1971), although it is often used interchangeably with
‘substance’. In the pharmacological definition, all
psychoactive compounds, from caffeine to heroin, should
be defined as drugs.
Drugs/substance use The ingestion of a psychoactive
agent to produce a desired behavioural, physiological or
psychopharmacological state.
Problematic drugs/substance use Regular, excessive
consumption and/or dependence on illegal psychoactive
compounds, leading to social, psychological, physical or
legal problems (that cause harm to the individual, their
significant others or the wider community). It can include
adverse effects on interpersonal skills; or functioning in
work, school, or social settings. 
Drugs/substance misuse These terms are discouraged
by some professionals, who consider them judgemental.
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6  Results of fieldwork meetings
Drugs prevention intervention An activity or set of
activities used to help a group of people change their
drug-using behaviour. 
Drugs prevention programme The sum of all
intervention modules implemented by a coordinator.
Evaluation A systematic assessment of whether
(outcome evaluation) and/or how (process evaluation) the
objectives of an intervention have been achieved. 
6.2  Programme delivery
Suggestions 
• Service providers need to work with a representative
sample of the young people they aim to target to ensure
the interventions are relevant, appropriate and credible. 
• Competent staff are essential to get vulnerable young
people interested.
• Educators and service providers should develop
interactive approaches to equip young people with the
skills they need to make an informed decision about
drugs use.
• Sessions involving active participation should be used
to build up long-term relationships with young people.
• Multi-agency working and information sharing should be
commonplace. It should be coordinated at regional level
and subject to independent monitoring and evaluation.
• External contributors should be assigned clear roles
and expectations to ensure consistent and coordinated
approaches and to avoid duplication of effort (for
example, police officers in schools should talk about
the legal consequences of drugs). External contributors
should also share and support the ethos of the
organisation’s prevention strategy. 
• A range of methods are recommended to target
specific populations (for example, social marketing
techniques) and for research (tools such as the Internet
and libraries). 
Barriers 
• Education techniques and training skills need to be
developed through accredited and/or standardised
courses.
• Opportunities for training people to deliver drugs
prevention programmes are limited due to a lack of
resources or time.
• Negative educational experiences may reduce the
effectiveness of school-based interventions, or reduce
the likelihood of personal disclosure and honesty about
drugs.
• Organisational and legal restrictions pose a barrier. 
For example, if protocol restricts the breaking of
confidentiality, or promotes a ‘zero tolerance’
approach. Similarly, some workers do not wish to
breach the personal confidences and trust established
with a client.
Solutions
• Drugs prevention providers should be informed of
approved agencies/organisations to consult if they have
a problem or concern.
• Involving existing youth organisations with drug
prevention initiatives builds on the credibility of these
organisations.
• Exciting and inspiring environments should be used to
deliver the intervention. 
• Any ‘personal contracts’ with young people (for
example, regarding behaviour and mutual expectations
resulting from participation) should clearly state that
the service deliverer would act if they believe that the
welfare of the individual is of concern. Section 8 of the
Misuse of Drugs Act (controlled drugs use on premises)
may provide justification for taking further action in
particular circumstances (for example, if a residential
service is provided).
6.3  Research and evaluation
Suggestions
• Prevention programmes should include a research
element.
• Prevention programmes should have clearly defined
aims and expected outcomes and should measure the
behaviour being addressed. The impact on attitudes
and knowledge should not be measured by self-report
alone. 
• Evaluations should be designed in parallel with, and
not after, the project. 
• Evaluation should be realistic about what constitutes a
success or failure and indicate over what time period
any benefits will be measured.
• As well as distinguishing between effective and
ineffective interventions (and offering explanations),
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evaluations help to support decisions on the quality 
of evidence arising from an intervention. (There are
wide differences in the quality of published
evaluations/research and these should be explored 
and understood)
• Different outcome measures have their own benefits
and disadvantages.
• In some circumstances, generic health and social
improvements are more important than specific ones
related to drugs use.
• Rigorous process evaluation is essential. It helps to
explain successes and failures, some of which may not
be entirely related to the intervention.
Barriers
• Sources of funding and funding criteria impact on the
choice of outcome measures. Some projects do not
include an evaluation component.
• Often, service providers show a lack of interest in
robust evaluation.
• Service providers’ understanding of what constitutes
evaluation varies and there is confusion about 
what each type of evaluation offers (for example, 
monitoring services versus process evaluation versus
outcome/impact evaluations). Process evaluation is
often incorrectly used as an outcome assessment. In
such cases, target group endorsement or enthusiasm is
confused with effectiveness.
• Some traditional outcome measures (for example,
temporary delay in onset of drugs use) may not be
meaningful, as drugs use is a product of other risky
behaviours which, if not addressed simultaneously, will
reoccur.
• The fidelity of an intervention needs to be
operationally defined in line with the reality of delivery
(for example, delivering an intervention in a busy
classroom).
• The value of evaluation findings is limited when
generalising to other populations, social environments
or geographic locations.
• Unsuccessful projects are less well publicised, which
means practitioners cannot learn from other people’s
mistakes. 
Solutions
• Raise awareness of the value and usefulness of good
quality evaluation studies, in terms of good practice
and appeal to funders.
• Allocate pilot or priming funds for services to conduct
small projects. This will reduce the risk of conducting
costly and ineffective interventions.
• Pool resources to increase the providers’ capacity to
evaluate programmes and ensure a coordinated
approach locally.
• Participants are useful process evaluators. They can
ensure a programme meets everybody’s expectations
(their own, the providers’ and the funders) and is
delivered with fidelity.
• Experienced practitioners or university researchers with
a background in prevention research should train
service providers in evaluation techniques. 
• There are alternative and cost effective ways of
evaluating short and long term projects. For example,
by utilising the skills of Master’s and PhD students.
6.4  Design and content
Suggestions
• Programmes with both generic and substance-specific
units are the most appropriate for young people.
• Content should be developed in consultation with –
and be relevant to – the targeted, at-risk population
and should address both health and lifestyle issues. 
• Creative, flexible content is essential to interest
vulnerable young people and to make them feel as if
they are developing several useful skills – not just drug-
related ones. 
• Innovative ideas and shared experiences are needed to
design an effective non-curricular based intervention in
schools.
• Generic strategies to reduce risk taking behaviours (for
example, impulsive decision making) will have a direct
and indirect effect on drug-using behaviour, and will
have a positive influence on other health-related
behaviours.
• In designing interventions to address or identify risky
behaviour (that is, drug use or its determinants) it must
be noted that an individual’s response to risk can
change over time, depending on their ability to cope
(for example, with challenging life events), and their
positive or negative experiences of drugs.
• Interventions should provide users with information
about the legal and social consequences of drugs use.
• Appreciation of the potential negative effects that
drugs use can have on work, relationships, community
and education provides a useful approach.
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• Parental components, such as homework sessions 
or family discussions about drugs are potentially 
useful.
• Subtle alterations in design and mode of delivery
(leaving core messages intact) will broaden the appeal
to both sexes. However, the fidelity of implementation
must always be considered. 
• Universal prevention interventions delivered to mixed
gender groups encourages young people to shape and
share their gender-based experiences, including, for
example, pressure in a relationship to use drugs.
• Young people are very aware of the media, so
accurate information delivered by a credible media
channel can be an effective way to target them.
Barriers
• Young people already involved in risky behaviours are
resistant to many health related messages. 
• There is no evidence base of good practice for
interventions with 18–25 year olds. 
• Sensational reporting in the popular media undermines
the credibility of anti-drugs related messages, and
prevents some parents from talking to their children
about drugs. 
• Often, parents show little interest in existing drugs
awareness schemes. This may be due to the stigma
associated with drugs use, their busy lives, or their
attitudes towards drugs use and education.
• Changes in social attitudes towards drugs and drugs
use will take a long time. 
• School exclusion and non-attendance are serious
barriers to delivery of school-based prevention
interventions.
• An over-reliance on information provision does not
allow young people to develop their self-esteem and
the interpersonal skills they need – such as the ability
to negotiate. 
• Skills development programmes should be clearly
defined.
Solutions
• Engagement with young people should take place at
the earliest opportunity. For example, through the
delivery of personal, social, and health education and
citizenship (PSHE and C) in schools. This begins at Key
Stage 1 and aims to gives pupils the knowledge, skills,
and understanding they need to lead healthy,
confident lives.
• Continuity in care plans/paths and multi-agency
working are especially important for young people at
risk of developing or making their drugs problem
worse. Tailoring the messages to ensure they are
relevant to the individual concerned will increase
effectiveness.
• Mentoring (establishing a relationship between two
people where one is a role model who will offer advice
and guidance) is a useful way of identifying and
responding to individual needs.
• Sensationalism should be challenged through the
promotion and dissemination of evidence-based,
dispassionate information about drugs and drugs use. 
• School attendance is a very strong protective factor
against drugs use and so must be maintained as far as
possible; exclusion must be a last resort.
6.5  Indicated and vulnerable groups and
individuals
Suggestions
• Focusing on those identified as most at-risk could lead
to labelling and stigmatisation. In addition, other
vulnerable sub-populations could be missed. 
• Although care plans can be useful tools, taking action
according to the plan can be challenging, especially if
more than one agency is involved.
• Retention of participants may be difficult due to the
factors that made the young person vulnerable in the
first place. Responses to disengagement may take the
form of crisis management (which simply aims to keep
the young person on the programme) rather than
trying to continue with specific drug prevention work.
Solutions 
• Recruitment processes and the content of targeted
approaches need to be sensitive to the target audience
and their parents or care-givers. This could be achieved
by screening at key transition points such as when
pupils move between schools.
• Structures for effective multi agency working should be
in place.
• Retention is more likely if participants find the
programmes interesting and meaningful and they are
delivered in a flexible manner. Staff efforts to build
trusting relationships are key.
One of the main objectives of this evidence into practice
briefing is to facilitate the exchange of drugs prevention
evidence so that local/regional/national practitioners and
administrations can monitor the quality and the evolution
of their interventions. An incremental system of
dissemination is proposed so that people can access the
type of evidence they need from the following sources.
• Dedicated websites featuring case studies that put
across key learning points and hyperlinks to related
material. 
• Conferences where people can exchange information
and network (although the ‘silent majority’ are unlikely
to participate in discussions).
• Interactive workshops and sessions which respond to
the needs of the audience. Topics could include, for
example, how to conduct evaluations. 
• Participation in evaluations (in other words,
organisations and individuals that provide drug
prevention should receive constructive feedback).
• Regional meetings with strategic leads to disseminate
evidence among – and within – organisations.
In addition, specialised drugs education is needed for
health undergraduates and graduates to reach the health
professionals of the future.
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7  Dissemination of good practice
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Drugs use in the UK consistently exceeds that of other
European countries. It has been estimated that 3 million
people in England and Wales aged 16 to 24 have used
illicit drugs (Chivite-Matthews et al. 2005). Younger age
of initiation is associated with potentially greater years of
ill health, poorer academic performance and a stronger
likelihood of progression onto problematic patterns of use. 
Drug use has direct and indirect economic and social
costs, and problematic drug use can be a burden on
families and communities. 
Increased understanding of the reasons why young
people use drugs – and the role that drugs play in their
lives – means that drugs use cannot be considered in
isolation. Indeed, there is a strong relationship with other
risky social and personal behaviours and activities. 
The most successful prevention interventions provide both
generic and specific support in response to changing
needs and circumstances. Drugs prevention is therefore 
a means of addressing a range of health-related
behaviours, reducing health inequalities and promoting
social inclusion.
This briefing has presented a range of evidence for key
stakeholders and offered important points of
consideration for those trying to put this evidence into
practice. Success requires collaborative working at a
number of stages: building up an evidence base,
translating the evidence into practice, and subsequently
evaluating it to inform the evidence base. All these stages
require appropriate structures and funding. 
This briefing was produced jointly by a number of
stakeholders working together to improve the quality and
provision of drugs prevention initiatives and support
available for young people. 
If implemented, these findings could help change various
parts of the healthcare system and have an impact on the
wider determinants of health. Different stakeholders can
alter certain variables to increase the likelihood of getting
evidence-based recommendations into practice. 
8  Concluding remarks
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National and local government strategy
This includes: 
• Updated Drug Strategy 2002 (www.drugs.gov.uk)
• Drugs Bill (www.publications.parliament.uk)
• Every Child Matters: Change for Children
(www.everychildmatters.gov.uk)
• Hidden Harm: Responding to the Needs of Children of
Problem Drug Users (www.drugs.gov.uk)
• Choosing Health: making healthier choices easier
(www.dh.gov.uk)
• National Service Framework for children, young people
and maternity services (www.dh.gov.uk)
• Drugs: Guidance for Schools
(www.dfes.gov.uk/drugsguidance)
• D(A)AT young people’s plans 
• National Healthy Schools Programme
(www.wiredforhealth.gov.uk)
• National Curriculum (www.dfes.gov.uk).
Current evidence
Available from organisations such as the 
National Collaborating Centre for Drug Prevention
(NCCDP – www.cph.org.uk/nccdp), NICE
(www.publichealth.nice.org.uk) and the Drugs Strategy
Directorate (www.drugs.gov.uk), as well as from the
academic literature and databases such as those run 
by the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA – www.emcdda.eu.int) 
and the National Institute on Drug Abuse (NIDA –
www.nida.nih.gov)
Examples of ‘best practice’
Find out if strategies are based on evidence-based
interventions (via peer reviewed sources such as the 
Drug Education and Prevention Information Service 
(DEPIS – hosted at www.dh.gov.uk) and the Exchange 
on Drug Demand Reduction Action (EDDRA –
http://eddra.emcdda.eu.int). Despite their apparent
success, consider whether programmes in the USA can be
transferred to a UK context.
Gaps in service provision
Needs assessment studies and consultation with target
groups will identify any gaps. Inclusive, creative thinking
will offer solutions to fill these gaps.
Local strategies
Joined-up local working is needed to bring together the
relevant ‘hooks/levers’ and to link in with relevant local
strategies including: Children’s Fund delivery plans,
parenting strategies, the young people’s substance
misuse strategy; the alcohol harm reduction strategy;
Connexions business plans, Healthy Schools partnership
plans, crime reduction strategies, Prevent and Deter
strategy, Education Development Plans; Teenage
Pregnancy Strategy; Children and Young People’s Plan.
Local partner organisations
Existing strategic partnerships and delivery plans need to
be taken into account when introducing new ways of
working.
Local champions 
These need to be identified and supported. They include
members of community groups, youth workers and
teachers.
Key influences
Include the effectiveness of the primary/secondary care
interface, economics, judicial policy and practice and local
education.
Resources
Implementation of evidence-based practice is likely to
have funding implications and there will be areas where
money can be saved (for example, by closing ineffective
programmes). Start-up, staff recruitment and continued
professional development, evaluation and dissemination
of findings all need to be well resourced.
Barriers 
Interventions may need to overcome cultural,
organisational and individual barriers to change 
(see section 6).
APPENDIX 1
Considerations when designing a drug prevention implementation strategy 
Workforce issues
Who is likely to be involved and what are their skills and
competencies? Do they need awareness training and
education? Do people need to be recruited? Will new
roles and career paths be required?
Potential implications for other services if evidence is
put into practice
The overall costs and benefits will have a knock-on effect
on crime, health, social inclusion, education, community
development, family relationships, parental support and
training services. Leaders in these fields need to be
consulted.
22 Drug use prevention among young people Evidence into practice briefing February 2006
23Drug use prevention among young people Evidence into practice briefing February 2006
Political drivers and imperatives
What is driving the content and shape of the work plan?
Decision makers
Who holds local power to make and influence decisions
for change? How can the decision making process be
accessed?
Partnerships – who works together?
What is understood by ‘partnership’? How important is it
to local politicians, the PCT, local authority, emergency
services, schools, health visitors, nurses and voluntary
agencies. What is the driver encouraging the PCT and LA
to sustain partnership working? What is the role of the
voluntary sector in planning and delivery? For further
discussion see the HDA/NICE publication Partnership
working: a consumer guide to resources (HDA 2003).
Budget
Who manages the budget? Identify those sectors that
need to be accountable.
Other resources
Can include people, professional time and facilities.
Stakeholders
Identify who they are. Do they include people living in the
local community, community workers and frontline staff
(in the NHS, local authorities and the voluntary sector)?
Consultation
Is it comprehensive?
Commissioning
Is the commissioning process evidence-based or
historical? Does it take account of national, regional and
local evidence of need, evidence of effectiveness and 
cost effectiveness? Is there a local evidence base of
effectiveness and need?
Shared data and information services
Is there an overarching data collection and information
system? What is required to achieve shared data services?
Performance management
Do performance targets relate to public health promotion
and prevention practice, or mainly serve as a monitoring
tool?
APPENDIX 2
Common public health issues and levers 
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Executives, managers, commissioners and budget
holders 
• Work in partnership to address underlying
determinants of health and barriers to population
health gain.
• Create public policy promoting healthy lifestyle choices
in young people.
• Support development of capacity to deliver
interventions promoting prevention of drugs use in
young people.
• Develop evidence-based public health policy to
promote prevention of drugs use among young
people, particularly those in deprived communities. 
• Develop local implementation strategies to support
pilot, community-based ‘holistic’ prevention
programmes.
• Develop leadership skills for action on health
inequalities.
• Fund needs and health impact assessments to
determine local population needs. 
• Fund pilots of new or innovative evidence-based
schemes via local strategic partnerships. 
• Fund longer-term prevention programmes where
pilot/research evidence shows effectiveness.
• Fund organisational and workforce development to
support delivery of drugs prevention interventions. 
• Fund ‘alternative’ evaluators such as funded PhD
students, university/practitioner-led training workshops
and courses.
• Identify and address community, structural and cultural
barriers to developing integrated drugs prevention
programmes.
Service providers
Objectives
• Develop awareness of drugs within the broader
context of young people’s lives: improving their
general health, social skills and education may be more
important than focusing on specific drugs use related
outcomes.
• Develop awareness of individual and group barriers to
engagement with services. 
• Develop research and evaluation to improve practice.
• Develop ways of verifying drugs use without relying on
self-reporting.
• Take part in evaluation training and make use of
participant evaluation.
• Strive to be active participants in training and
professional development.
• Work with the media to present positive views of
young people, and rational, evidence-based
information about drugs and drugs use. 
• Monitor sources of referral and use external providers
(including professional training and other resources)
where appropriate. 
• Maintain non-drugs using behaviour by promoting 
and reinforcing protective factors (such as positive
schooling).
• Share project successes and failures via the DEPIS and
EDDRA online databases and a variety of media.
Community-based professionals
Objectives
• Work with all sectors and in all settings to share
appropriate information, develop networks and engage
communities.
• Identify training needs and deliver training to support
development of drugs prevention programmes.
• Assess local needs, resources and capacity to develop
and deliver community-based drugs prevention
programmes.
• Identify structural and cultural barriers to the
development of community-based drugs prevention
programmes and how to address them.
• Identify potential community leaders and champions.
Engage
• Provide individuals and groups with training, skills
development and support. 
• Ensure community-based drugs prevention
programmes are integrated with other initiatives 
(for example, in schools via the national curriculum and
Healthy Schools and via initiatives supported by the
NRF). 
APPENDIX 3
A summary of key stakeholders’ objectives (sections 1.1–1.4)
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Academics, designers, planners and evaluators
Objectives
• Create and evaluate a wide range of activities based
on drugs prevention theories.
• Work at all levels to disseminate intervention and
research outcomes through a variety of media and
presentation techniques.
• Influence and determine local and national discourse
and priorities on drugs and drugs use, to share
research and evaluation skills.
• Identify the determinants and promoters of drug use
as well as protective factors – in particular, associated
behaviours that may be amenable to change.
• Refine and test specific interventions.
